We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Midatech Pharma Plc | LSE:MTPH | London | Ordinary Share | GB00BNGF1L75 | ORD GBP0.02 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.00 | 17.00 | 19.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMTPH
RNS Number : 0479S
Midatech Pharma PLC
03 July 2020
3 July 2020
Midatech Pharma PLC
("Midatech" or the "Company")
Posting of Annual Report & Notice of AGM
Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that its Notice of Annual General Meeting ("AGM") was posted to shareholders today, along with the Annual Report and Financial Statements for the year ended 31 December 2019. The document is also available on the "Investors" section of the Company's website at www.midatechpharma.com/financial-reports-accounts.
The Company will be holding its AGM at its offices at Oddfellows House, 19 Newport Road, Cardiff CF24 0AA at 11.30am on 31 July 2020.
Due to the ongoing guidance in relation to the current Covid-19 pandemic, it is highly likely that shareholders will be required to submit proxy votes at the AGM only, as physical attendance will not be possible. The Board encourages shareholders to complete and submit their proxy form as early as possible and to only appoint the Chairman of the AGM to act as their proxy.
The Company is investigating options to allow shareholders to join the AGM virtually and there will also be the opportunity for shareholders to submit questions in advance of the AGM. The arrangements for this will be notified via an RNS announcement and on the Company's website as soon as they are finalised.
For more information, please contact:
Midatech Pharma PLC Stephen Stamp, CEO, CFO Tel: +44 (0)1235 888300 www.midatechpharma.com Panmure Gordon (UK) Limited (Nominated Adviser and Broker) Freddy Crossley, Emma Earl (Corporate Finance) James Stearns (Corporate Broking) Turner Pope Investments (TPI) Limited (Joint Broker) Andrew Thacker (Corporate Broking) Tel: +44(0)20 3657 0050 IFC Advisory Limited (Financial PR and UK Investor Relations) Tim Metcalfe / Graham Herring Tel: +44 (0)20 3934 6630 Email: midatech@investor-focus.co.uk Edison Group (US Investor Relations) Joseph Green/ Laine Yonker Tel: (646) 653-7030/ 7035 jgreen@edisongroup.com/ lyonker@edisongroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NOAEAKXDELLEEFA
(END) Dow Jones Newswires
July 03, 2020 12:48 ET (16:48 GMT)
1 Year Midatech Pharma Chart |
1 Month Midatech Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
